Green Planet Bio Engineering Co. Ltd. financial data

Symbol
GPLB on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
20807 Biscayne Blvd., Suite 203, Aventura, Florida
Fiscal year end
December 31
Former names
Mondo Acquisition II, Inc. (to 10/9/2008)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0 %
Return On Equity 8.94 % -12.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 20M shares 0%
Common Stock, Shares, Outstanding 20M shares 0%
Entity Public Float 722K USD +57.1%
Common Stock, Value, Issued 20K USD 0%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 10.9K USD +27.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -10.9K USD -27.4%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -38.6K USD +2.93%
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 0 USD
Assets, Current 0 USD
Accounts Payable, Current 8.95K USD
Liabilities, Current 447K USD +9.46%
Retained Earnings (Accumulated Deficit) -1.08M USD -3.72%
Stockholders' Equity Attributable to Parent -447K USD -9.46%
Liabilities and Equity 0 USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.97K USD +33.6%
Net Cash Provided by (Used in) Financing Activities 7.97K USD -33.6%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 20M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 0 USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 259K USD +5.03%
Deferred Tax Assets, Operating Loss Carryforwards 259K USD +5.03%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 610K USD 0%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%